15 Sep 2025 | 5 Mins Read
Jefferies picks Divi’s, Cohance, and Sai Life as top pharma stocks
Flipitmoney
Jefferies expects India's CRDMO sector to grow robustly over the next three to five years, driven by tailwinds such as differentiated capabilities and the China+1 opportunity. The brokerage recommends four stocks: Divi's Laboratories with a 19% upside, Cohance Lifesciences with a 17% upside, Sai Life Sciences with a 26% upside, and Piramal Pharma with a 30% upside.